Albemarle Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -15.94%

Albemarle Corporation EBITDA Margin is -15.94% for the Trailing 12 Months (TTM) ending March 31, 2025, a 178.88% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Albemarle Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -5.72%, a -113.45% change year over year.
  • Albemarle Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 42.49%, a 680.35% change year over year.
  • Albemarle Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 5.45%, a -76.51% change year over year.
  • Albemarle Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 23.18%, a -8.85% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin